Literature DB >> 20584522

A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder.

Jeanette M Jerrell1, Roger S McIntyre, Avnish Tripathi.   

Abstract

OBJECTIVE: To identify the association between medical or psychiatric comorbidities, clinical characteristics, or course of illness/recovery in pediatric bipolar disorder (BD).
METHOD: Data from the South Carolina Medicaid program covering all medical services and medication prescriptions between January 1996 and December 2005 were used to analyze the temporal onset of 12 comorbid medical or psychiatric conditions for 1,841 children and adolescents diagnosed with BD using DSM-IV-TR criteria and for a random sample of 4,500 children not treated for psychiatric disorders. The primary outcome measures were diagnostic codes and regression analyses of patterns of acute and outpatient treatment services for BD over time.
RESULTS: Ten conditions examined were significantly more prevalent in the BD cohort: obesity, type 2 diabetes mellitus, endocrine disorders, migraine headaches, central nervous system (CNS) disorders/epilepsy, organic brain disorders/mental retardation, cardiovascular disorders, attention-deficit/hyperactivity disorder (ADHD), asthma, and substance abuse (P ≤ .01). For clinical characteristics within the BD cohort, an adolescent-onset diagnosis of BD (age ≥13 years) was significantly associated with the diagnosis of preexisting obesity, hypertension, migraine, mental retardation, endocrine disorders, and substance abuse (P ≤ .05), whereas recurrent depressive episodes were associated with preexisting endocrine disorders and substance abuse. Preexisting ADHD, substance abuse, CNS disorders/epilepsy, cardiovascular disorders, obesity, and asthma were associated with higher overall medical and psychiatric outpatient and acute service use, but none of these comorbid disorders differentially impacted the course of illness or recovery for BD.
CONCLUSIONS: Neuropsychiatric (ie, ADHD, substance abuse, CNS disorders/epilepsy) and medical (ie, obesity, asthma, cardiovascular disease) disorders temporally precede the diagnosis of early-onset BD in pediatric patients and are associated with discrete facets of illness presentation, but they do not substantially alter the clinical course of the BD over time. © Copyright 2010 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20584522     DOI: 10.4088/JCP.09m05585ora

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  36 in total

Review 1.  Risk of myocardial infarction and stroke in bipolar disorder: a systematic review and exploratory meta-analysis.

Authors:  M L Prieto; A B Cuéllar-Barboza; W V Bobo; V L Roger; F Bellivier; M Leboyer; C P West; M A Frye
Journal:  Acta Psychiatr Scand       Date:  2014-05-22       Impact factor: 6.392

2.  High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder.

Authors:  Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A Axelson; Daniel P Dickstein; Tina R Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D Ryan; Michael A Strober; Martin B Keller; Benjamin I Goldstein
Journal:  J Clin Psychiatry       Date:  2019-07-30       Impact factor: 4.384

Review 3.  White matter hyperintensities: from medical comorbidities to bipolar disorders and back.

Authors:  Eva Gunde; Ryan Blagdon; Tomas Hajek
Journal:  Ann Med       Date:  2011-07-13       Impact factor: 4.709

4.  Parental and comorbid migraine in individuals with bipolar disorder: A nationwide register study.

Authors:  Dan Sucksdorff; Alan S Brown; Roshan Chudal; Markus Heinimaa; Auli Suominen; Andre Sourander
Journal:  J Affect Disord       Date:  2016-07-19       Impact factor: 4.839

5.  Community Mental Health Providers' Beliefs About Addressing Weight Loss Among Youth Clients with Serious Emotional Disturbance and Overweight/Obesity: An Elicitation Study.

Authors:  Thomas L Wykes; Katelynn A Bourassa; Andrea E Slosser; Christine L McKibbin
Journal:  Community Ment Health J       Date:  2018-02-09

Review 6.  Is it time for immunopsychiatry in psychotic disorders?

Authors:  Marion Leboyer; José Oliveira; Ryad Tamouza; Laurent Groc
Journal:  Psychopharmacology (Berl)       Date:  2016-03-18       Impact factor: 4.530

7.  Parental and comorbid epilepsy in persons with bipolar disorder.

Authors:  Dan Sucksdorff; Alan S Brown; Roshan Chudal; Elina Jokiranta-Olkoniemi; Susanna Leivonen; Auli Suominen; Markus Heinimaa; Andre Sourander
Journal:  J Affect Disord       Date:  2015-09-02       Impact factor: 4.839

Review 8.  Bipolar disorder: new perspectives in health care and prevention.

Authors:  Marion Leboyer; David J Kupfer
Journal:  J Clin Psychiatry       Date:  2010-12       Impact factor: 4.384

9.  Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders.

Authors:  Benjamin I Goldstein; Katelyn A Collinger; Francis Lotrich; Anna L Marsland; Mary-Kay Gill; David A Axelson; Boris Birmaher
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-10       Impact factor: 2.576

10.  Genetic association study between the detected risk variants based upon type II diabetes GWAS and psychotic disorders in the Japanese population.

Authors:  Yusuke Kajio; Kenji Kondo; Takeo Saito; Yoshimi Iwayama; Branko Aleksic; Kazuo Yamada; Tomoko Toyota; Eiji Hattori; Hiroshi Ujike; Toshiya Inada; Hiroshi Kunugi; Tadafumi Kato; Takeo Yoshikawa; Norio Ozaki; Masashi Ikeda; Nakao Iwata
Journal:  J Hum Genet       Date:  2013-11-07       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.